In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.
暂无分享,去创建一个
F. Veiga | D. Ferreira | Laura S S Ribeiro | Domingos C Ferreira | Francisco J B Veiga | Laura Ribeiro
[1] V. Stella,et al. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent. , 2001, Journal of pharmaceutical sciences.
[2] I. Tucker,et al. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. , 2000, International journal of pharmaceutics.
[3] Y. Qiu,et al. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method. , 2003, Journal of pharmaceutical sciences.
[4] M. T. Karad,et al. A novel method for the study of water absorption rates by swellable matrices , 2003 .
[5] P Mura,et al. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] F. Jamali,et al. Stereoselective Dissolution of Propranolol Hydrochloride from Hydroxypropyl Methylcellulose Matrices , 1993, Pharmaceutical Research.
[7] Christos Reppas,et al. Forecasting the In Vivo Performance of Four Low Solubility Drugs from Their In Vitro Dissolution Data , 1999, Pharmaceutical Research.
[8] A. Concheiro,et al. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[9] L. Villafuerte-Robles,et al. Effect of varying the restriction degree of 4-aminopyridine release from HPMC matrices on the mechanism controlling the process. , 2003, International journal of pharmaceutics.
[10] M. Jug,et al. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] O. Corrigan,et al. Mechanism of drug dissolution rate enhancement from β‐cyclodextrin‐drug systems , 1982 .
[12] J. Dressman,et al. Forecasting the Oral Absorption Behavior of Poorly Soluble Weak Bases Using Solubility and Dissolution Studies in Biorelevant Media , 2002, Pharmaceutical Research.
[13] F. Giordano,et al. Solid-state characterization and dissolution characteristics of gliclazide-β-cyclodextrin inclusion complexes , 1997 .
[14] J. Szejtli,et al. Cyclodextrins in Pharmacy , 1993 .
[15] R. Löbenberg,et al. Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.
[16] R. Le Verge,et al. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. , 1999, Journal of pharmaceutical sciences.
[17] J. Ayres,et al. Drug release from spray layered and coated drug-containing beads: effects of pH and comparison of different dissolution methods. , 1999, Drug development and industrial pharmacy.
[18] E. Jorgensen,et al. Development of dissolution tests for oral extended-release products , 1998 .
[19] L. Vereczkey,et al. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine. , 2001, Polish journal of pharmacology.
[20] K. A. Khan. The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.
[21] F. Veiga,et al. Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] Thomas O'Hara,et al. A REVIEW OF METHODS USED TO COMPARE DISSOLUTION PROFILE DATA , 1998 .
[23] Paulo Mayorga,et al. Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] B. Aungst,et al. Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes. , 2002, Journal of pharmaceutical sciences.
[25] Domingos Ferreira,et al. Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes. , 2003, Chemical & pharmaceutical bulletin.
[26] A. Rajabi-Siahboomi,et al. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[27] F. Hirayama,et al. Design and In‐vitro Evaluation of a Modified‐release Oral Dosage Form of Nifedipine by Hybridization of Hydroxypropyl‐β‐cyclodextrin and Hydroxypropylcellulose , 1993, The Journal of pharmacy and pharmacology.
[28] J. Dressman,et al. Drug Release Characteristics of Different Mesalazine Products Using USP Apparatus 3 to Simulate Passage Through the GI Tract , 2002 .
[29] Lin Shan-yang,et al. Solid particulates of drug-β-cyclodextrin inclusion complexes directly prepared by a spray-drying technique , 1989 .
[30] F. Veiga,et al. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[31] M. Siewert. FIP Guidelines for Dissolution Testing of Solid Oral Products (Final Draft, 1995) , 1996 .
[32] J. W. Moore,et al. Mathematical comparison of dissolution profiles , 1996 .
[33] J. Polli,et al. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. , 1997, Journal of pharmaceutical sciences.
[34] F. Giordano,et al. Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices. , 2001, Biomaterials.
[35] A. Shukla,et al. Comparison of Three Dissolution Devices for Evaluating Drug Release , 1994 .
[36] J. Dressman,et al. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.
[37] Roger A. Rajewski,et al. Cyclodextrins: Their Future in Drug Formulation and Delivery , 1997, Pharmaceutical Research.
[38] B. Rohrs,et al. USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations. , 1995, Journal of pharmaceutical sciences.
[39] N. Peppas,et al. Drug diffusion front movement is important in drug release control from swellable matrix tablets. , 1995, Journal of pharmaceutical sciences.